共 33 条
- [1] Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J. Clin, 71, pp. 209-249, (2021)
- [2] Martha O., Balan D., Porav-Hodade D., Dragus E., Vartolomei M.D., Chibelean C.B., Borda A., Pytel A., Vida O.A., The role of neutrophil to lymphocyte ratio in patients with pTa non-muscle invasive bladder cancer, Rev. Romana De Med. De Lab, 28, pp. 29-38, (2020)
- [3] Antoni S., Ferlay J., Soerjomataram I., Znaor A., Jemal A., Bray F., Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends, Eur. Urol, 71, pp. 96-108, (2017)
- [4] Teoh J.Y.-C., Huang J., Ko W.Y.-K., Lok V., Choi P., Ng C.-F., Sengupta S., Mostafid H., Kamat A.M., Black P.C., Et al., Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita, Eur. Urol, 78, pp. 893-906, (2020)
- [5] Wong M.C.S., Fung F.D.H., Leung C., Cheung W.W.L., Goggins W.B., Ng C.F., The global epidemiology of bladder cancer: A joinpoint regression analysis of its incidence and mortality trends and projection, Sci. Rep, 8, (2018)
- [6] Burger M., Catto J.W.F., Dalbagni G., Grossman H.B., Herr H., Karakiewicz P., Kassouf W., Kiemeney L.A., La Vecchia C., Shariat S., Et al., Epidemiology and risk factors of urothelial bladder cancer, Eur. Urol, 63, pp. 234-241, (2013)
- [7] Witjes J.A., Bruins H.M., Carrion A., Cathomas R., Comperat E., Efstathiou J.A., Fietkau R., Gakis G., Lorch A., Martini A., Et al., European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines, Eur. Urol, 85, pp. 17-31, (2024)
- [8] Babjuk M., Burger M., Comperat E.M., Gontero P., Mostafid A.H., Palou J., van Rhijn B.W.G., Roupret M., Shariat S.F., Sylvester R., Et al., European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ), Eur. Urol, 81, pp. 75-94, (2022)
- [9] Holzbeierlein J., Bixler B.R., Buckley D.I., Chang S.S., Holmes R.S., James A.C., Kirkby E., McKiernan J.M., Schuckman A., Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017
- [10] Amended 2020, 2024), J. Urol, 212, pp. 3-10, (2024)